» Articles » PMID: 28011513

Tumescent Anesthesia in Skin- and Nipple-sparing Mastectomy: Results of a Prospective Clinical Study

Overview
Journal Anticancer Res
Specialty Oncology
Date 2016 Dec 25
PMID 28011513
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The tumescent mastectomy technique has been used to facilitate dissection of subcutaneous tissue and mammary gland in order to reduce intraoperative bleeding and speed the operation.

Patients And Methods: A prospective clinical study was performed on 30 female patients undergoing immediate breast reconstructions after skin-sparing mastectomy (SSM) or nipple-sparing mastectomy (NSM) in order to assess early postoperative complications, pain, and final esthetic outcome of skin flaps related to tumescent anesthesia (TA).

Results: TA significantly speeded-up the operative procedure (131±49.99 vs. 180.5±67.15 min; p=0.03) achieving less skin damage compared to patients who did not have TA (p=0.045); moreover, no significant difference occurred with regard to the length of in-hospital stay and overall lymphatic drainage.

Conclusion: The length of the operation as well as the final cosmetic outcome of skin flaps was significantly improved due to TA, with no appreciable side-effects.

Citing Articles

Back to the future: breast surgery with tumescent local anesthesia (TLA)?.

Boeer B, Helms G, Pasternak J, Roehm C, Kofler L, Haefner H Arch Gynecol Obstet. 2023; 308(3):935-940.

PMID: 36872392 PMC: 10348980. DOI: 10.1007/s00404-023-06938-5.


Complication Differences Between the Tumescent and Non-Tumescent Dissection Techniques for Mastectomy: A Meta-Analysis.

Yang Y, Zhu J, Qian X, Feng J, Sun F Front Oncol. 2022; 11:648955.

PMID: 35083131 PMC: 8785857. DOI: 10.3389/fonc.2021.648955.


Population pharmacokinetic model for tumescent lidocaine in women undergoing breast cancer surgery.

Riff C, Bourgoin A, Marsot A, Allanioux L, Leone M, Blin O Eur J Clin Pharmacol. 2018; 74(10):1309-1315.

PMID: 29909577 DOI: 10.1007/s00228-018-2503-8.